Free Trial

Vicarious Surgical (RBOT) Competitors

Vicarious Surgical logo
$6.35 -0.24 (-3.70%)
Closing price 03/28/2025 03:59 PM Eastern
Extended Trading
$6.40 +0.06 (+0.91%)
As of 03/28/2025 07:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

RBOT vs. AVR, ZJYL, MLSS, NTRB, APT, SPAI, CLGN, COCH, LFWD, and POAI

Should you be buying Vicarious Surgical stock or one of its competitors? The main competitors of Vicarious Surgical include Anteris Technologies Global (AVR), Jin Medical International (ZJYL), Milestone Scientific (MLSS), Nutriband (NTRB), Alpha Pro Tech (APT), Safe Pro Group Inc. Common Stock (SPAI), CollPlant Biotechnologies (CLGN), Envoy Medical (COCH), ReWalk Robotics (LFWD), and Predictive Oncology (POAI). These companies are all part of the "surgical appliances & supplies" industry.

Vicarious Surgical vs.

Vicarious Surgical (NYSE:RBOT) and Anteris Technologies Global (NASDAQ:AVR) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, community ranking, media sentiment, institutional ownership, earnings, profitability, valuation and risk.

Vicarious Surgical received 4 more outperform votes than Anteris Technologies Global when rated by MarketBeat users. However, 100.00% of users gave Anteris Technologies Global an outperform vote while only 32.00% of users gave Vicarious Surgical an outperform vote.

CompanyUnderperformOutperform
Vicarious SurgicalOutperform Votes
8
32.00%
Underperform Votes
17
68.00%
Anteris Technologies GlobalOutperform Votes
4
100.00%
Underperform Votes
No Votes

Anteris Technologies Global's return on equity of 0.00% beat Vicarious Surgical's return on equity.

Company Net Margins Return on Equity Return on Assets
Vicarious SurgicalN/A -81.46% -63.62%
Anteris Technologies Global N/A N/A N/A

Anteris Technologies Global has higher revenue and earnings than Vicarious Surgical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Vicarious SurgicalN/AN/A-$71.07M-$10.85-0.58
Anteris Technologies Global$2.71M50.49N/AN/AN/A

Vicarious Surgical currently has a consensus target price of $9.25, indicating a potential upside of 45.76%. Anteris Technologies Global has a consensus target price of $16.50, indicating a potential upside of 334.21%. Given Anteris Technologies Global's stronger consensus rating and higher possible upside, analysts clearly believe Anteris Technologies Global is more favorable than Vicarious Surgical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Vicarious Surgical
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Anteris Technologies Global
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
3.00

47.3% of Vicarious Surgical shares are held by institutional investors. 11.7% of Vicarious Surgical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

In the previous week, Anteris Technologies Global had 3 more articles in the media than Vicarious Surgical. MarketBeat recorded 4 mentions for Anteris Technologies Global and 1 mentions for Vicarious Surgical. Anteris Technologies Global's average media sentiment score of 0.74 beat Vicarious Surgical's score of 0.00 indicating that Anteris Technologies Global is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Vicarious Surgical
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Anteris Technologies Global
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Anteris Technologies Global beats Vicarious Surgical on 9 of the 12 factors compared between the two stocks.

Remove Ads
Get Vicarious Surgical News Delivered to You Automatically

Sign up to receive the latest news and ratings for RBOT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RBOT vs. The Competition

MetricVicarious SurgicalSurgical appliances & supplies IndustryMedical SectorNYSE Exchange
Market Cap$37.49M$8.83B$5.63B$19.39B
Dividend YieldN/A1.42%5.33%3.76%
P/E Ratio-0.6218.1023.6033.06
Price / SalesN/A66.77388.2326.59
Price / CashN/A19.6738.1717.55
Price / Book0.385.416.894.53
Net Income-$71.07M$284.66M$3.20B$1.02B
7 Day Performance-18.43%-2.68%-3.06%-1.30%
1 Month Performance-42.54%-5.35%1.52%-4.04%
1 Year Performance-29.84%-23.28%9.37%2.55%

Vicarious Surgical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RBOT
Vicarious Surgical
2.0222 of 5 stars
$6.35
-3.7%
$9.25
+45.8%
-29.8%$37.49MN/A-0.623
AVR
Anteris Technologies Global
N/A$5.12
-1.2%
$16.50
+222.3%
N/A$184.44M$2.71M0.00138News Coverage
High Trading Volume
ZJYL
Jin Medical International
N/A$0.72
+10.1%
N/A-81.7%$113.40M$23.50M0.00245
MLSS
Milestone Scientific
1.7016 of 5 stars
$1.01
flat
$1.25
+23.8%
+58.9%$78.67M$8.88M-14.4330Gap Up
NTRB
Nutriband
3.2559 of 5 stars
$6.83
+1.5%
$13.00
+90.3%
+38.5%$75.85M$2.02M-9.6210Short Interest ↓
Positive News
APT
Alpha Pro Tech
N/A$5.05
+0.6%
N/A-19.6%$54.91M$57.84M13.65120Analyst Forecast
News Coverage
SPAI
Safe Pro Group Inc. Common Stock
N/A$2.94
+0.7%
N/AN/A$40.45M$1.56M0.0011
CLGN
CollPlant Biotechnologies
2.8238 of 5 stars
$3.11
+0.3%
$12.50
+301.9%
-52.3%$35.63M$650,000.00-2.0270Earnings Report
Analyst Forecast
Short Interest ↓
News Coverage
High Trading Volume
COCH
Envoy Medical
2.5581 of 5 stars
$1.42
-1.0%
$8.00
+465.4%
-65.3%$28.65M$278,000.000.0034Gap Up
LFWD
ReWalk Robotics
2.4126 of 5 stars
$1.80
+4.7%
$9.00
+400.0%
-65.8%$19.13M$25.66M-0.7260Short Interest ↑
POAI
Predictive Oncology
2.2477 of 5 stars
$1.12
+0.5%
$3.00
+169.1%
-43.1%$7.63M$1.48M-0.3730Short Interest ↓
News Coverage
Remove Ads

Related Companies and Tools


This page (NYSE:RBOT) was last updated on 3/30/2025 by MarketBeat.com Staff
From Our Partners